(Q39418448)

11 September 2017

High mobility group protein AT-hook 1 (HMGA1) is associated with the development of androgen independence in prostate cancer cells (English)

1 reference

11 September 2017

Ichiro Takeuchi

1

1 reference

11 September 2017

Natsuki Takaha

2

1 reference

11 September 2017

Terukazu Nakamura

3

1 reference

11 September 2017

Fumiya Hongo

4

1 reference

11 September 2017

Kazuya Mikami

5

1 reference

11 September 2017

Kazumi Kamoi

6

1 reference

11 September 2017

Koji Okihara

7

1 reference

11 September 2017

Akihiro Kawauchi

8

1 reference

11 September 2017

Tsuneharu Miki

9

1 reference

11 September 2017

27 December 2011

1 reference

11 September 2017

1 reference

11 September 2017

72

1 reference

11 September 2017

1124-1132

1 reference

11 September 2017

10

1 reference

11 September 2017

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22460

Roles of HMGA proteins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22460

HMGA1 inhibits the function of p53 family members in thyroid cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22460

High-mobility group protein 1(Y): metastasis-associated or metastasis-inducing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22460

A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22460

High mobility group protein HMGI(Y) enhances tumor cell growth, invasion, and matrix metalloproteinase-2 expression in prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22460

Nuclear matrix localization of high mobility group protein I(Y) in a transgenic mouse model for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22460

Caveolin expression is decreased following androgen deprivation in human prostate cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22460

HMGA1 controls transcription of insulin receptor to regulate cyclin D1 translation in pancreatic cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22460

Hypoxia induces high-mobility-group protein I(Y) and transcription of the cyclooxygenase-2 gene in human vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22460

Tumor promoter induces high mobility group HMG-Y protein expression in transformation-sensitive but not -resistant cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22460

Induction of high mobility group-I(Y) protein by endotoxin and interleukin-1beta in vascular smooth muscle cells. Role in activation of inducible nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22460

HMG-I/Y, a new c-Myc target gene and potential oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22460

HMGA1 enhances the transcriptional activity and binding of the estrogen receptor to its responsive element

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22460

Mechanisms of androgen-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22460

Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22460

Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22460

NF-kappaB2/p52 enhances androgen-independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen-deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22460

Syndecan-1, a new target molecule involved in progression of androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22460

21 January 2018

Identifiers

DOI

10.1002/PROS.22460

1 reference

11 September 2017

1 reference